These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 38322496)

  • 1. Early ultrasonic vocalization deficits and related thyroarytenoid muscle pathology in the transgenic TgF344-AD rat model of Alzheimer's disease.
    Rudisch DM; Krasko MN; Barnett DGS; Mueller KD; Russell JA; Connor NP; Ciucci MR
    Front Behav Neurosci; 2023; 17():1294648. PubMed ID: 38322496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model.
    Smith LA; McMahon LL
    Neurobiol Dis; 2018 Feb; 110():166-179. PubMed ID: 29199135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia.
    Voorhees JR; Remy MT; Cintrón-Pérez CJ; El Rassi E; Khan MZ; Dutca LM; Yin TC; McDaniel LN; Williams NS; Brat DJ; Pieper AA
    Biol Psychiatry; 2018 Oct; 84(7):488-498. PubMed ID: 29246437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease.
    Morrone CD; Lai AY; Bishay J; Hill ME; McLaurin J
    Transl Neurodegener; 2022 May; 11(1):26. PubMed ID: 35501886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence in support of a prodromal respiratory control signature in the TgF344-AD rat model of Alzheimer's disease.
    Lucking EF; Murphy KH; Burns DP; Jaisimha AV; Barry-Murphy KJ; Dhaliwal P; Boland B; Rae MG; O'Halloran KD
    Respir Physiol Neurobiol; 2019 Jul; 265():55-67. PubMed ID: 29969703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model of Alzheimer's Disease: A longitudinal MRI study.
    Anckaerts C; Blockx I; Summer P; Michael J; Hamaide J; Kreutzer C; Boutin H; Couillard-Després S; Verhoye M; Van der Linden A
    Neurobiol Dis; 2019 Apr; 124():93-107. PubMed ID: 30445024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical and cognitive changes precede structural abnormalities in the TgF344-AD rat model.
    Fowler CF; Goerzen D; Devenyi GA; Madularu D; Chakravarty MM; Near J
    Brain Commun; 2022; 4(2):fcac072. PubMed ID: 35434622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatio-temporal metabolic rewiring in the brain of TgF344-AD rat model of Alzheimer's disease.
    Muñoz-Moreno E; Simões RV; Tudela R; López-Gil X; Soria G
    Sci Rep; 2022 Oct; 12(1):16958. PubMed ID: 36216838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor RG2833 has therapeutic potential for Alzheimer's disease in females.
    Ndukwe K; Serrano PA; Rockwell P; Xie L; Figueiredo-Pereira M
    bioRxiv; 2023 Dec; ():. PubMed ID: 38234827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular changes in TgF344-AD rat model of Alzheimer's disease.
    Tsai Y; Lu B; Ljubimov AV; Girman S; Ross-Cisneros FN; Sadun AA; Svendsen CN; Cohen RM; Wang S
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):523-34. PubMed ID: 24398104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in theta-gamma coupling and sharp wave-ripple, signs of prodromal hippocampal network impairment in the TgF344-AD rat model.
    van den Berg M; Toen D; Verhoye M; Keliris GA
    Front Aging Neurosci; 2023; 15():1081058. PubMed ID: 37032829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodromal dysfunction of α5GABA-A receptor modulated hippocampal ripples occurs prior to neurodegeneration in the TgF344-AD rat model of Alzheimer's disease.
    Ratner MH; Downing SS; Guo O; Odamah KE; Stewart TM; Kumaresan V; Robitsek RJ; Xia W; Farb DH
    Heliyon; 2021 Sep; 7(9):e07895. PubMed ID: 34568591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease.
    Kelberman MA; Rorabaugh JM; Anderson CR; Marriott A; DePuy SD; Rasmussen K; McCann KE; Weiss JM; Weinshenker D
    Neurobiol Aging; 2023 May; 125():98-108. PubMed ID: 36889122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage attenuation of phase-amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease.
    Bazzigaluppi P; Beckett TL; Koletar MM; Lai AY; Joo IL; Brown ME; Carlen PL; McLaurin J; Stefanovic B
    J Neurochem; 2018 Mar; 144(5):669-679. PubMed ID: 28777881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Females exhibit higher GluA2 levels and outperform males in active place avoidance despite increased amyloid plaques in TgF344-Alzheimer's rats.
    Chaudry O; Ndukwe K; Xie L; Figueiredo-Pereira M; Serrano P; Rockwell P
    Sci Rep; 2022 Nov; 12(1):19129. PubMed ID: 36352024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive impairment of directional and spatially precise trajectories by TgF344-Alzheimer's disease rats in the Morris Water Task.
    Berkowitz LE; Harvey RE; Drake E; Thompson SM; Clark BJ
    Sci Rep; 2018 Nov; 8(1):16153. PubMed ID: 30385825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual dimorphism in the peripheral metabolic homeostasis and behavior in the TgF344-AD rat model of Alzheimer's disease.
    Srivastava H; Lasher AT; Nagarajan A; Sun LY
    Aging Cell; 2023 Jul; 22(7):e13854. PubMed ID: 37095621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered basal forebrain function during whole-brain network activity at pre- and early-plaque stages of Alzheimer's disease in TgF344-AD rats.
    van den Berg M; Adhikari MH; Verschuuren M; Pintelon I; Vasilkovska T; Van Audekerke J; Missault S; Heymans L; Ponsaerts P; De Vos WH; Van der Linden A; Keliris GA; Verhoye M
    Alzheimers Res Ther; 2022 Oct; 14(1):148. PubMed ID: 36217211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.